Esperion Therapeutics (ESPR) Return on Assets (2013 - 2026)

Esperion Therapeutics has reported Return on Assets for 14 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q1 2026, with the low at 0.01% in Q4 2023.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.0% in 2025.
• Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2024, when it gained 1 bps.
• Esperion Therapeutics' Return on Assets stood at 0.01% in 2022, then fell by 19 bps to 0.01% in 2023, then jumped by 96 bps to 0.0% in 2024, then sank by 47 bps to 0.0% in 2025, then jumped by 66 bps to 0.0% in 2026.
• The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.